Financial Ratios

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2090.10-12.25 (-0.58 %)
PREV CLOSE ( ) 2102.35
OPEN PRICE ( ) 2106.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 583
TODAY'S LOW / HIGH ( )2068.60 2109.05
52 WK LOW / HIGH ( )1171 2425.1
NSE2094.00-15.65 (-0.74 %)
PREV CLOSE( ) 2109.65
OPEN PRICE ( ) 2149.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5063
TODAY'S LOW / HIGH( ) 2080.00 2166.45
52 WK LOW / HIGH ( )1177.55 2439.95
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)32.5784.5789.7917.1632.58
   CEPS(Rs)45.3596.99101.7528.9242.78
   DPS(Rs)1.751.751.751.751.75
   Book NAV/Share(Rs)365.04334.36251.62163.81149.11
   Tax Rate(%)24.3724.2527.0126.1226.99
Margin Ratios
   Core EBITDA Margin(%)10.4420.6929.8413.7421.08
   EBIT Margin(%)10.3422.2430.2911.1619.66
   Pre Tax Margin(%)9.6721.6429.449.4318.00
   PAT Margin (%)7.3116.4021.486.9713.14
   Cash Profit Margin (%)10.1918.8024.3511.7417.25
Performance Ratios
   ROA(%)7.1121.6130.706.9614.25
   ROE(%)9.3128.8643.2210.9724.52
   ROCE(%)11.5034.7151.9013.6527.63
   Asset Turnover(x)0.971.321.431.001.08
   Sales/Fixed Asset(x)2.863.603.111.962.23
   Working Capital/Sales(x)2.682.983.063.823.72
Efficiency Ratios
   Fixed Capital/Sales(x)0.350.280.320.510.45
   Receivable days86.3158.6845.0671.1372.43
   Inventory Days54.4653.2546.4755.7742.20
   Payable days66.7465.4973.5497.43110.66
Valuation Parameters
   PER(x)36.7523.1517.0714.7614.42
   PCE(x)26.3920.1915.078.7610.98
   Price/Book(x)3.285.866.091.553.15
   Yield(%)0.150.090.110.690.37
   EV/Net Sales(x)2.763.893.711.192.05
   EV/Core EBITDA(x)20.8915.7711.207.498.63
   EV/EBIT(x)26.7017.4812.2610.7010.43
   EV/CE(x)2.634.464.661.172.11
   M Cap / Sales2.693.803.671.031.89
Growth Ratio
   Net Sales Growth(%)-13.6923.4369.65-0.6534.77
   Core EBITDA Growth(%)-53.76-8.22253.09-33.4350.58
   EBIT Growth(%)-59.90-9.35360.65-43.6353.47
   PAT Growth(%)-61.49-5.81423.12-47.3259.33
   EPS Growth(%)-61.49-5.81423.12-47.3259.33
Financial Stability Ratios
   Total Debt/Equity(x)0.140.150.110.280.29
   Current Ratio(x)2.812.693.151.931.91
   Quick Ratio(x)2.331.822.181.281.50
   Interest Cover(x)15.5537.0735.496.4711.82
   Total Debt/Mcap(x)0.040.020.020.180.09

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.